SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-23-000106
Filing Date
2023-11-07
Accepted
2023-11-07 17:00:44
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20230930.htm   iXBRL 10-Q 1281666
2 EX-31.1 lumo-2023930x10qxex3111.htm EX-31.1 10027
3 EX-31.2 lumo-2023930x10qxex3121.htm EX-31.2 10078
4 EX-32.1 lumo-2023930x10qxex3211.htm EX-32.1 7067
10 GRAPHIC nlnk-20230930_g1.jpg GRAPHIC 12762
11 GRAPHIC nlnk-20230930_g2.jpg GRAPHIC 29752
12 GRAPHIC nlnk-20230930_g3.jpg GRAPHIC 138603
  Complete submission text file 0001126234-23-000106.txt   4702173

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20230930.xsd EX-101.SCH 22957
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20230930_cal.xml EX-101.CAL 41056
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20230930_def.xml EX-101.DEF 91159
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20230930_lab.xml EX-101.LAB 321648
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20230930_pre.xml EX-101.PRE 191560
43 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20230930_htm.xml XML 473220
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 231384928
SIC: 2834 Pharmaceutical Preparations